Olfactory Dysfunction in Parkinson's Disease
JNNP 62:436-446, Hawkes,C.H.,et al, 1997
Serotonin Syndrome and the Combined Use of Deprenyl and An Antidepressant in Parkinson's Disease
Neurol 48:1070-1077, Richard,I.H.,et al, 1997
New Variant Creutzfeldt-Jakob Disease:Neurological Features and Diagnostic Tests
Lancet 350:903-907, Zeidler,M.,et al, 1997
The Expansion of the CAG Repeat in Ataxin-2 is a Frequent Cause of Autosomal Dominant Spinocerebellar Ataxia
Neurol 49:1009-1013, Lorenzetti,D.,et al, 1997
Spinocerebellar Ataxia Type 6, Molecular & Clin Features of 35 Japanese Pts (1 Homozygous for CAG Repeat Expan)
Neurol 49:1238-1243, 11961997., Matsumura,R.,et al, 1997
Diagnosis of Chronic Manganese Intoxication by Magnetic Resonance Imaging
NEJM 336:965-966, Arjona,A.,et al, 1997
Immunologic Analysis of Spinal Cord-Biopsy Specimen from a Pt with HTLV-I-Associated Neurologic Disease
NEJM 336:839-845, Levin,M.C.,et al, 1997
Mortality from Parkinson Disease
Arch Neurol 54:260-264, Louis,E.D.,et al, 1997
P3 Latency Change in Aging and Parkinson Disease
Arch Neurol 54:296-302, Tachibana,H.,et al, 1997
MR of Childhood Metachromatic Leukodystrophy
AJNR 18:733-738, Kim,T.S.,et al, 1997
X Linked Adrenoleukodystrophy:Clinical Presentation, Diagnosis, and Therapy
JNNP 63:4-14, vanGeel,B.M.,et al, 1997
A 36-Year-Old Woman Recuperating From a Stroke
JAMA 277:1970-1976, Alexander,M., 1997
Pure or Predominant Sensory Stroke Due to Brain Stem Lesion
Stroke 28:1761-1764, Kim,J.S.&Bae,Y.H., 1997
Presymptomatic Hypertension is a Major Feature in the Diagnosis of Progressive Supranuclear Palsy
Arch Neurol 54:1104-1108, Ghika,J.&Bogousslavsky,J., 1997
Characterizing Swallowing Abnormalities in Progressive Supranuclear Palsy
Neurol 48:1654-1662, Litvan,I.,et al, 1997
Clinicopath Conf
Progressive Supranuclear Palsy, Case 26, 1997, NEJM 337:549-55697., , 1997
Corticobasal Degeneration:Neuropathologic and Clinical Heterogeneity
Neurol 48:959-969, Schneider,J.A.,et al, 1997
High-Frequency Unilateral Thalamic Stimulation in the Treatment of Essential and Parkinsonian Tremor
Ann Neurol 42:292-299, Koller,W.,et al, 1997
High-Frequency Stimulation of the Globus Pallidus for the Treatment of Parkinson's Disease
Neurol 49:249-253, Pahwa,R.,et al, 1997
Clinical Characteristics of a Chromosome 17-Linked Rapidly Progressive Familial Frontotemporal Dementia
Arch Neurol 54:539-544, Basun,H.,et al, 1997
Balance in the Healthy Elderly
Arch Neurol 54:976-981, Camicioli,R.,et al, 1997
Pain After Thalamic Stroke:Right Diencephalic Predominance and Clinical Features in 180 Patients
Neurol 48:1196-1199, Nasreddine,Z.S.&Saver,J.L., 1997
Low-Dose Clozapine Improves Dyskinesias in Parkinson's Disease
Neurol 48:658-662, Durif,F.,et al, 1997
Gabapentin for Parkinsonism:A Double-Blind Placebo-Controlled, Crossover Trial
Am J med 102:60-66, Olson,W.L.,et al, 1997
Ataxia and Slurred Speech after Artesunate Treatment for Falciparum Malaria
NEJM 336:1328, Miller,L.G.&Panosian,C.B., 1997
Gene Locus for Autosomal Recessive Distal Myopathy with Rimmed Vacuoles Maps to Chromosome 9
Ann Neurol 41:432-437, Ikeuchi,T.,et al, 1997
Familial Nature and Continuing Morbidity of the Amyotrophic Lateral Sclerosis-Parkinsonism Dementia Complex of Guam
Neurol 49:400-409, McGeer,P.L.,et al, 1997
Clinicopath Conf
Hodgkin's Disease, Paraneoplastic Cerebellar Degeneration, Case 21-1997, NEJM 337:115-12297., , 1997
Paraneoplastic Cerebellar Degeneration
Arch Int Med 157:1258-1262, Bolla,L.&Palmer,R.M., 1997
Tizanidine for Spasticity
The Medical Letter 39:62, , 1997
Benztropine vs Clozapine for the Treatment of Tremor in Parkinson's Disease
Neurol 48:1077-1081, Friedman,J.H.,et al, 1997
A Survey of Antidepressant Drug Use in Parkinson's Disease
Neurol 49:1168-1170, Richard,I.H.,et al, 1997
Hallucinosis in Idiopathic Parkinson's Disease
JNNP 63:434-440, Graham,J.M.,et al, 1997
Double-Blind Comparison of Pramipexole & Bromocriptine Trtm with Placebo in Advanced Parkinson's Disease
Neurol 49:1060-1065, Guttman,M.,et al, 1997
COMT Inhibition with Tolcapone Reduces the"Wearing Off"Phenomenon & Levodopa Requirements in Fluctuating Parkinsonisn Pts
JNNP 63:421-428, Baas,H.,et al, 1997
Tolcapone Improves Motor Function in Parkinsonian Pts with the"Wearing Off"Phenomenon
Neurol 49:1066-1071, Rajput,A.H.,et al, 1997
Entacapone Improves Motor Fluctuations in Levodopa-Treated Parkinson's Dis Pts
Parkinson Study Group, Ann Neurol 42:747-7551997., , 1997
Adult-Onset Krabbe Disease with Mutation in the Galactocerebrosidase Gene, MRI of Corticospinal Tract Demyelin
Neurol 49:1392-1399, Satoh,J.-I.,et al, 1997
Smoking and Parkinson's Disease, An Age-Dependent Risk Effect
Neurol 49:1267-1272, Tzourio,C.,et al, 1997
Clozapine in Parkinson's Disase Tremor, Effets of Acute and Chronic Administration
Neurol 49:1587-1590, Bonuccelli,U.,et al, 1997
CSF Antigliadin Antibodies and the Ramsay Hunt Syndrome
Neurol 49:1131-1133, Chinnery,P.F.,et al, 1997
Posteroventral Medial Pallidotomy in Advanced Parkinson's Disease
NEJM 337:1036-1042, Lang,A.E.,et al, 1997
Chemosensory Event-Related Potentials in Response to Trigeminal & Olfactory Stim in Idio Parkinson's Dis
Neurol 49:1424-1431, Barz,S.,et al, 1997
Olfactory Dysfunction in Familial Parkinsonism
Neurol 49:1262-1267, Markopoulou,K.,et al, 1997
Sympathetic Cardioneuropathy in Dysautonomias
NEJM 336:696-702, 7211997., Goldstein,D.S.,et al, 1997
Parkinsonism Associated with Long-Term Cocaine Abuse
Arch Int Med 157:241, Domingo,P.&Martinez,E., 1997
Accuracy of the Clinical Diagnosis of Corticobasal Degeneration:A clinicopathologic Study
Neurol 48:119-125, Litvan,I.,et al, 1997
Is There a Gulf War Syndrome? Searching for Syndromes by Factor Analysis of Symptoms
JAMA 227:215-222, 2591997., Haley,R.W.,et al, 1997
Self-Reported Exposure to Neurotoxic Chemical Combinations in the Gulf War:A Cross-Sectional Epidemiologic Study
JAMA 227:231-237, 2591997., Haley,R.W.&Kurt,T.L., 1997
HTLV-Associated Myelopathy in a Cohort of HTLV-I and HTLV-II Infected Blood Donors
neurol 48:315-320, Murphy,E.L.,et al, 1997